抗抑郁药
优势比
萧条(经济学)
医学
精神科
可能性
认知
数字符号替换试验
重性抑郁障碍
重性抑郁发作
三环类抗抑郁药
心理学
内科学
临床心理学
逻辑回归
焦虑
经济
病理
替代医学
宏观经济学
安慰剂
作者
Shakila Meshkat,Michelle Wu,Vanessa K. Tassone,Reinhard Janssen‐Aguilar,Hilary Pang,Hye Jung Jung,Wendy Lou,Venkat Bhat
摘要
Abstract Introduction The relationship between antidepressant use and class with cognition in depression is unclear. This study aimed to evaluate the association of cognition with depressive symptoms and antidepressant use (class, duration, number). Methods Data from the National Health and Nutrition Examination Survey were examined for cognitive function through various tests and memory issues through the Medical Conditions questionnaire. Depressive symptoms were assessed using the Patient Health Questionnaire-9. Results A total of 2867 participants were included. Participants with depressive symptoms had significantly higher odds of cognitive impairment (CI) on the animal fluency test (aOR=1.89, 95% CI=1.30, 2.73, P=0.002) and Digit Symbol Substitution test (aOR=2.58, 95% CI=1.34, 4.9, P=0.007), as well as subjective memory issues (aOR=7.25, 95% CI=4.26, 12.32, P<0.001) than those without depression. There were no statistically significant associations between any of the CI categories and depressive symptoms treated with an antidepressant and antidepressant use duration. Participants who were using more than one antidepressant had significantly higher odds of subjective memory issues than those who were using one antidepressant. Specifically, users of atypical antidepressants, selective serotonin reuptake inhibitors, or tricyclic antidepressants (TCAs) had significantly higher odds of subjective memory issues in comparison to no antidepressants, with TCAs showing the largest odds (aOR=4.21, 95% CI=1.19, 14.86, P=0.028). Discussion This study highlights the relationship between depressive symptoms, antidepressant use, and CI. Future studies should further evaluate the mechanism underlying this phenomenon.
科研通智能强力驱动
Strongly Powered by AbleSci AI